EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective Role of MerTK in Diabetic Peripheral Neuropathy via Inhibition of the NF-κB Signaling Pathway

Xiaoyang Su, Wenting Chen, Yidan Fu, Bian Wu, Fugang Mao, Yan Zhao, Qiuping Yang, Danfeng Lan

Experimental and Clinical Endocrinology & Diabetes · 01.07.2024 · 132 (07) · 396-406

DOI: 10.1055/a-2301-3970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.07.2024. Verfasst von Xiaoyang Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Diabetic Neuropathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, the Yunnan Key Laboratory of Innovative Application of Traditional Chinese Medicine, the Yunnan Health Training Project of High Level Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic peripheral neuropathy (DPN) impacts patient quality of life. In such patients, increased expression of mer tyrosine kinase (MerTK) has been demonstrated; however, its mechanism of action remains unclear. In this study, type 2 diabetes mellitus (T2DM) and DPN models were established in Sprague Dawley rats via low-dose streptozotocin and a high-fat diet and the mode of action of MerTK was examined.

Methods

MerTK-specific inhibitors were administered by gavage once daily for 2 weeks. Sciatic nerve conduction velocity and nerve structure were measured. The levels of MerTK, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and relevant biochemical indexes were detected.

Results

The study revealed upregulation of MerTK expression in T2DM and more so in DPN groups. Inhibiting MerTK led to reduced nerve conduction velocity and further deterioration of sciatic nerve structure, as evidenced by structural morphology. Concurrently, serum levels of total cholesterol, glycated hemoglobin, and triglyceride significantly increased. Moreover, levels of NF-κB increased in both serum and nerve tissue, alongside a significant rise in TNF-α and IL-1β expressions. MerTK could bind to the inhibitor of kappa B kinase beta (Ikbkb) in Schwann cells, establishing Ikbkb as a precursor to NF-κB activation.

Discussion

Inhibition of MerTK exacerbates neuropathy, indicating its protective role in DPN by suppressing the NF-κB pathway, highlighting a potential new target for its diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

c-Mer Tyrosine KinaseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic NeuropathiesNF-kappa BRats, Sprague-DawleySignal TransductionAnimalsMaleRats

Substanzen

c-Mer Tyrosine KinaseNF-kappa BMertk protein, rat

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
  • Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
  • Department of General Surgery II, The First People's Hospital of Yunnan Province, Yunnan Key Laboratory of Innovative Application of Traditional Chinese Medicine, Kunming 650032, Yunnan, China.
  • Department of Ultrasound, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China.
  • Department of Gastroenterology, The First People's Hospital of Yunnan Province, Yunnan Digestive Disease Clinical Medical Center, Kunming 650032, Yunnan, China.

Förderung

  • National Natural Science Foundation of China
  • the Yunnan Key Laboratory of Innovative Application of Traditional Chinese Medicine
  • the Yunnan Health Training Project of High Level Talents
  • the Special Joint Program of Yunnan Province

Zitieren

APA

Su, X., Chen, W., Fu, Y., Wu, B., Mao, F., Zhao, Y., Yang, Q., & Lan, D. (2024). Protective Role of MerTK in Diabetic Peripheral Neuropathy via Inhibition of the NF-κB Signaling Pathway. Experimental and Clinical Endocrinology & Diabetes, 132(07), 396-406. https://doi.org/10.1055/a-2301-3970

Vancouver

Su X, Chen W, Fu Y, Wu B, Mao F, Zhao Y, et al. Protective Role of MerTK in Diabetic Peripheral Neuropathy via Inhibition of the NF-κB Signaling Pathway. Experimental and Clinical Endocrinology & Diabetes. 2024;132(07):396-406. doi:10.1055/a-2301-3970

BibTeX
@article{Su2024,
  author = {Su, Xiaoyang and Chen, Wenting and Fu, Yidan and Wu, Bian and Mao, Fugang and Zhao, Yan and Yang, Qiuping and Lan, Danfeng},
  title = {Protective Role of MerTK in Diabetic Peripheral Neuropathy via Inhibition of the NF-κB Signaling Pathway},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2024},
  volume = {132},
  number = {07},
  pages = {396--406},
  doi = {10.1055/a-2301-3970}
}
Kostenlos starten →